Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

NCT00014222 PHASE3 COMPLETED Results posted

RATIONALE: 1. . To compare the effects on breast cancer of three different combinations of drugs which are commonly used to treat this disease. 2. . It is not yet known which treatment regimen is most effective for breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy given with or without epoetin alfa in treating women who have undergone surgery for stage I, stage II, or stage III breast cancer.

Details

Lead sponsor	NCIC Clinical Trials Group
Phase	PHASE3
Status	COMPLETED
Enrolment	2104
Start date	Mon Dec 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Mar 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Breast Cancer

Interventions

• epoetin alfa
• filgrastim
• cyclophosphamide
• doxorubicin hydrochloride
• epirubicin hydrochloride
• fluorouracil
• paclitaxel

Countries

Canada, United States